In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
138 News Items found
Scott Lowe
Cell Surface Protein uPAR May Hold the Key to Targeting Solid Tumors with CAR T Cell Therapy

MSK researchers and collaborators have developed a new type of CAR T cell designed to attack a cell surface protein called uPAR — allowing them to target both tumors and cancer-supporting cells in the tumor microenvironment.
MSK gynecologic surgeon Dr. Mario Leitao and Dr. Anh Le.
Patient Story
Full Circle: MSK Patient Survives Deadly Cervical Cancer and Returns to Train as Doctor

Read about a medical student treated at MSK for aggressive cervical cancer who later returned to train alongside MSK surgeons.
Close up of gloved hands working in a lab
MSK Research Highlights September 29, 2023

New research from MSK develops a method for analyzing cancer cells that survive treatment for acute myeloid leukemia; identifies a transcription factor that orchestrates natural killer cell response; and finds vepafestinib is a promising therapeutic for the treatment of RET-driven cancers.
An MSK research notebook on a bench in a lab
MSK Research Highlights, August 10, 2023

New MSK research finds a potential target against neuroendocrine transformation in lung and prostate cancers; discovers new clues about why donor T cells attack certain tissues in graft-versus-host disease; sheds light on why T cells let go of their prey; and uses CRISPR interference and dynamic cell-state transitions to discover enhancers that affect early human development.
A lab coat with an MSK logo hangs on a hook
Meet the 2025 Graduates of the Gerstner Sloan Kettering Graduate School

Fourteen young scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 14, 2025, as part of Memorial Sloan Kettering’s 46th annual academic convocation.
Andi Straus and her son, Nadav, pose on a hiking trail.
Targeted Therapy Shows Promising Results Against Rare Soft Tissue Sarcoma

A clinical trial led by doctors from MSK has found that abemaciclib — a drug already approved for certain breast cancers — can significantly slow the growth of dedifferentiated liposarcoma, a rare, aggressive soft tissue cancer.
Doctors operating
New Facility Eases Patient Experience and Promotes Collaborative Treatment and Research

On June 7 when Memorial Sloan Kettering opened a facility housing the novel Center for Image-Guided Interventions, a suite of endoscopy rooms, and new operating rooms for the Surgical Day Hospital.
Medical oncologist Bill Tap examines a patient
Feature
Outsmarting Sarcoma: How MSK’s Experts Are Advancing Treatment and Research Progress

Spend a day with the expert team in MSK's world-renowned sarcoma service.